Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Fate of /sup 111/In-labeled platelets during cardiopulmonary bypass performed with membrane and bubble oxygenators

Journal Article · · J. Thorac. Cardiovasc. Surg.; (United States)
OSTI ID:6718346
To elucidate the effects of bubble and membrane oxygenators on platelet integrity, we developed a quantitative method of determining platelet lysis during cardiopulmonary bypass. Two groups of dogs whose platelets had been labeled with /sup 111/In were subjected to 1 hour of cardiopulmonary bypass. In Group A (bubble oxygenator), platelet lysis as measured by free plasma /sup 111/In levels increased from 6% +/- 1% to 33% +/- 7% during bypass. In Group B (membrane oxygenator), plasma /sup 111/In levels increased from 5% +/- 2% to 10% +/- 6% during bypass (p less than 0.01). After 1 hour of bypass, the ratio of /sup 111/In-labeled platelets to prebypass levels was 36% +/- 8% in Group A and 67% +/- 9% in Group B. Platelet deposition on the oxygenator was greater in bubble oxygenators (19% +/- 4% of total injected /sup 111/In) than in membrane oxygenators (12% +/- 3% of total injected 111In). These data indicated that membrane oxygenators maintain a higher circulating platelet count both intraoperatively and postoperatively and result in less platelet destruction than bubble oxygenators following 1 hour of cardiopulmonary bypass in dogs.
Research Organization:
Mayo Clinic and Foundation, Rochester, MN
OSTI ID:
6718346
Journal Information:
J. Thorac. Cardiovasc. Surg.; (United States), Journal Name: J. Thorac. Cardiovasc. Surg.; (United States) Vol. 84:1; ISSN JTCSA
Country of Publication:
United States
Language:
English